Pertussis Vaccine-EMEA Market Status and Trend Report 2013-2023
Report Summary
Pertussis Vaccine-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pertussis Vaccine industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Pertussis Vaccine 2013-2017, and development forecast 2018-2023
Main market players of Pertussis Vaccine in EMEA, with company and product introduction, position in the Pertussis Vaccine market
Market status and development trend of Pertussis Vaccine by types and applications
Cost and profit status of Pertussis Vaccine, and marketing status
Market growth drivers and challenges
The report segments the EMEA Pertussis Vaccine market as:
EMEA Pertussis Vaccine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Pertussis Vaccine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Whole-cell Vaccines
Acellular Vaccines
EMEA Pertussis Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children Application
Adults Application
EMEA Pertussis Vaccine Market: Players Segment Analysis (Company and Product introduction, Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin):
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma Corporation
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Beijing Tiantan Biological Products
Chengdu Institute of Biological Products
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pertussis Vaccine-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Pertussis Vaccine industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Pertussis Vaccine 2013-2017, and development forecast 2018-2023
Main market players of Pertussis Vaccine in EMEA, with company and product introduction, position in the Pertussis Vaccine market
Market status and development trend of Pertussis Vaccine by types and applications
Cost and profit status of Pertussis Vaccine, and marketing status
Market growth drivers and challenges
The report segments the EMEA Pertussis Vaccine market as:
EMEA Pertussis Vaccine Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Pertussis Vaccine Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Whole-cell Vaccines
Acellular Vaccines
EMEA Pertussis Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Children Application
Adults Application
EMEA Pertussis Vaccine Market: Players Segment Analysis (Company and Product introduction, Pertussis Vaccine Sales Volume, Revenue, Price and Gross Margin):
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma Corporation
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Beijing Tiantan Biological Products
Chengdu Institute of Biological Products
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PERTUSSIS VACCINE
1.1 Definition of Pertussis Vaccine in This Report
1.2 Commercial Types of Pertussis Vaccine
1.2.1 Whole-cell Vaccines
1.2.2 Acellular Vaccines
1.3 Downstream Application of Pertussis Vaccine
1.3.1 Children Application
1.3.2 Adults Application
1.4 Development History of Pertussis Vaccine
1.5 Market Status and Trend of Pertussis Vaccine 2013-2023
1.5.1 Asia Pacific Pertussis Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Pertussis Vaccine Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pertussis Vaccine in Asia Pacific 2013-2017
2.2 Consumption Market of Pertussis Vaccine in Asia Pacific by Regions
2.2.1 Consumption Volume of Pertussis Vaccine in Asia Pacific by Regions
2.2.2 Revenue of Pertussis Vaccine in Asia Pacific by Regions
2.3 Market Analysis of Pertussis Vaccine in Asia Pacific by Regions
2.3.1 Market Analysis of Pertussis Vaccine in China 2013-2017
2.3.2 Market Analysis of Pertussis Vaccine in Japan 2013-2017
2.3.3 Market Analysis of Pertussis Vaccine in Korea 2013-2017
2.3.4 Market Analysis of Pertussis Vaccine in India 2013-2017
2.3.5 Market Analysis of Pertussis Vaccine in Southeast Asia 2013-2017
2.3.6 Market Analysis of Pertussis Vaccine in Australia 2013-2017
2.4 Market Development Forecast of Pertussis Vaccine in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Pertussis Vaccine in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Pertussis Vaccine by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Pertussis Vaccine in Asia Pacific by Types
3.1.2 Revenue of Pertussis Vaccine in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Pertussis Vaccine in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pertussis Vaccine in Asia Pacific by Downstream Industry
4.2 Demand Volume of Pertussis Vaccine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pertussis Vaccine by Downstream Industry in China
4.2.2 Demand Volume of Pertussis Vaccine by Downstream Industry in Japan
4.2.3 Demand Volume of Pertussis Vaccine by Downstream Industry in Korea
4.2.4 Demand Volume of Pertussis Vaccine by Downstream Industry in India
4.2.5 Demand Volume of Pertussis Vaccine by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Pertussis Vaccine by Downstream Industry in Australia
4.3 Market Forecast of Pertussis Vaccine in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PERTUSSIS VACCINE
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Pertussis Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 6 PERTUSSIS VACCINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Pertussis Vaccine in Asia Pacific by Major Players
6.2 Revenue of Pertussis Vaccine in Asia Pacific by Major Players
6.3 Basic Information of Pertussis Vaccine by Major Players
6.3.1 Headquarters Location and Established Time of Pertussis Vaccine Major Players
6.3.2 Employees and Revenue Level of Pertussis Vaccine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PERTUSSIS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sanofi Pasteur
7.1.1 Company profile
7.1.2 Representative Pertussis Vaccine Product
7.1.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Sanofi Pasteur
7.2 GSK
7.2.1 Company profile
7.2.2 Representative Pertussis Vaccine Product
7.2.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of GSK
7.3 Mitsubishi Tanabe Pharma Corporation
7.3.1 Company profile
7.3.2 Representative Pertussis Vaccine Product
7.3.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Mitsubishi Tanabe Pharma Corporation
7.4 Astellas Pharma
7.4.1 Company profile
7.4.2 Representative Pertussis Vaccine Product
7.4.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Astellas Pharma
7.5 Minhai Biotechnology
7.5.1 Company profile
7.5.2 Representative Pertussis Vaccine Product
7.5.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Minhai Biotechnology
7.6 Wuhan Institute of Biological Products
7.6.1 Company profile
7.6.2 Representative Pertussis Vaccine Product
7.6.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Wuhan Institute of Biological Products
7.7 Changchun Changsheng Life Sciences
7.7.1 Company profile
7.7.2 Representative Pertussis Vaccine Product
7.7.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Changchun Changsheng Life Sciences
7.8 Beijing Tiantan Biological Products
7.8.1 Company profile
7.8.2 Representative Pertussis Vaccine Product
7.8.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Beijing Tiantan Biological Products
7.9 Chengdu Institute of Biological Products
7.9.1 Company profile
7.9.2 Representative Pertussis Vaccine Product
7.9.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Chengdu Institute of Biological Products
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERTUSSIS VACCINE
8.1 Industry Chain of Pertussis Vaccine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PERTUSSIS VACCINE
9.1 Cost Structure Analysis of Pertussis Vaccine
9.2 Raw Materials Cost Analysis of Pertussis Vaccine
9.3 Labor Cost Analysis of Pertussis Vaccine
9.4 Manufacturing Expenses Analysis of Pertussis Vaccine
CHAPTER 10 MARKETING STATUS ANALYSIS OF PERTUSSIS VACCINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Pertussis Vaccine in This Report
1.2 Commercial Types of Pertussis Vaccine
1.2.1 Whole-cell Vaccines
1.2.2 Acellular Vaccines
1.3 Downstream Application of Pertussis Vaccine
1.3.1 Children Application
1.3.2 Adults Application
1.4 Development History of Pertussis Vaccine
1.5 Market Status and Trend of Pertussis Vaccine 2013-2023
1.5.1 Asia Pacific Pertussis Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Pertussis Vaccine Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Pertussis Vaccine in Asia Pacific 2013-2017
2.2 Consumption Market of Pertussis Vaccine in Asia Pacific by Regions
2.2.1 Consumption Volume of Pertussis Vaccine in Asia Pacific by Regions
2.2.2 Revenue of Pertussis Vaccine in Asia Pacific by Regions
2.3 Market Analysis of Pertussis Vaccine in Asia Pacific by Regions
2.3.1 Market Analysis of Pertussis Vaccine in China 2013-2017
2.3.2 Market Analysis of Pertussis Vaccine in Japan 2013-2017
2.3.3 Market Analysis of Pertussis Vaccine in Korea 2013-2017
2.3.4 Market Analysis of Pertussis Vaccine in India 2013-2017
2.3.5 Market Analysis of Pertussis Vaccine in Southeast Asia 2013-2017
2.3.6 Market Analysis of Pertussis Vaccine in Australia 2013-2017
2.4 Market Development Forecast of Pertussis Vaccine in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Pertussis Vaccine in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Pertussis Vaccine by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Pertussis Vaccine in Asia Pacific by Types
3.1.2 Revenue of Pertussis Vaccine in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Pertussis Vaccine in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Pertussis Vaccine in Asia Pacific by Downstream Industry
4.2 Demand Volume of Pertussis Vaccine by Downstream Industry in Major Countries
4.2.1 Demand Volume of Pertussis Vaccine by Downstream Industry in China
4.2.2 Demand Volume of Pertussis Vaccine by Downstream Industry in Japan
4.2.3 Demand Volume of Pertussis Vaccine by Downstream Industry in Korea
4.2.4 Demand Volume of Pertussis Vaccine by Downstream Industry in India
4.2.5 Demand Volume of Pertussis Vaccine by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Pertussis Vaccine by Downstream Industry in Australia
4.3 Market Forecast of Pertussis Vaccine in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF PERTUSSIS VACCINE
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Pertussis Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 6 PERTUSSIS VACCINE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Pertussis Vaccine in Asia Pacific by Major Players
6.2 Revenue of Pertussis Vaccine in Asia Pacific by Major Players
6.3 Basic Information of Pertussis Vaccine by Major Players
6.3.1 Headquarters Location and Established Time of Pertussis Vaccine Major Players
6.3.2 Employees and Revenue Level of Pertussis Vaccine Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 PERTUSSIS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Sanofi Pasteur
7.1.1 Company profile
7.1.2 Representative Pertussis Vaccine Product
7.1.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Sanofi Pasteur
7.2 GSK
7.2.1 Company profile
7.2.2 Representative Pertussis Vaccine Product
7.2.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of GSK
7.3 Mitsubishi Tanabe Pharma Corporation
7.3.1 Company profile
7.3.2 Representative Pertussis Vaccine Product
7.3.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Mitsubishi Tanabe Pharma Corporation
7.4 Astellas Pharma
7.4.1 Company profile
7.4.2 Representative Pertussis Vaccine Product
7.4.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Astellas Pharma
7.5 Minhai Biotechnology
7.5.1 Company profile
7.5.2 Representative Pertussis Vaccine Product
7.5.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Minhai Biotechnology
7.6 Wuhan Institute of Biological Products
7.6.1 Company profile
7.6.2 Representative Pertussis Vaccine Product
7.6.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Wuhan Institute of Biological Products
7.7 Changchun Changsheng Life Sciences
7.7.1 Company profile
7.7.2 Representative Pertussis Vaccine Product
7.7.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Changchun Changsheng Life Sciences
7.8 Beijing Tiantan Biological Products
7.8.1 Company profile
7.8.2 Representative Pertussis Vaccine Product
7.8.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Beijing Tiantan Biological Products
7.9 Chengdu Institute of Biological Products
7.9.1 Company profile
7.9.2 Representative Pertussis Vaccine Product
7.9.3 Pertussis Vaccine Sales, Revenue, Price and Gross Margin of Chengdu Institute of Biological Products
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PERTUSSIS VACCINE
8.1 Industry Chain of Pertussis Vaccine
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF PERTUSSIS VACCINE
9.1 Cost Structure Analysis of Pertussis Vaccine
9.2 Raw Materials Cost Analysis of Pertussis Vaccine
9.3 Labor Cost Analysis of Pertussis Vaccine
9.4 Manufacturing Expenses Analysis of Pertussis Vaccine
CHAPTER 10 MARKETING STATUS ANALYSIS OF PERTUSSIS VACCINE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
